Nanjing Yakshi Technology Co., Ltd. issued the 14th indicative announcement for early redemption of “Yakshi to Debt”. The conditional redemption clause was triggered because the closing price of the company's stock was not less than 130% of the current share conversion price for at least 15 out of 30 consecutive trading days. The company decided to exercise the right of early redemption on August 14, 2025. The redemption price of “Medicine Stone to Debt” is 100.62 yuan/sheet. The redemption registration date is September 17, and the redemption date is September 18. After the redemption is completed, it will be delisted from the Shenzhen Stock Exchange. Holders are reminded to pay attention to share transfers within a limited period of time; otherwise, they may face losses. It also reminds them of risks such as authority related to share transfers and the freezing of pledges.

Nanjing Yakshi Technology Co., Ltd. issued the 14th indicative announcement for early redemption of “Yakshi to Debt”. The conditional redemption clause was triggered because the closing price of the company's stock was not less than 130% of the current share conversion price for at least 15 out of 30 consecutive trading days. The company decided to exercise the right of early redemption on August 14, 2025. The redemption price of “Medicine Stone to Debt” is 100.62 yuan/sheet. The redemption registration date is September 17, and the redemption date is September 18. After the redemption is completed, it will be delisted from the Shenzhen Stock Exchange. Holders are reminded to pay attention to share transfers within a limited period of time; otherwise, they may face losses. It also reminds them of risks such as authority related to share transfers and the freezing of pledges.